Global Health Stock

Global Health EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Global Health (GLH.AX) as of Aug 9, 2026 is -5.58. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -3.53 — a change of 58.18% (lower).

EV/EBIT

-5.58

YoY

58.18%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Global Health is 2026 -5.58 . EV/EBIT (Enterprise Value to EBIT) of Global Health was 2025 -3.53 . It decreases by 58.18% lower compared to the previous year.

The Global Health EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
-6.23 base
Jan 1, 2020
-139.21 base
Jan 1, 2021
-1,786.20 base
Jan 1, 2022
-5.95 base
Jan 1, 2023
-1.85 base
Jan 1, 2024
-6.44 base
Jan 1, 2025
-6.43 base
Jan 1, 2026 (e)
-0.01 base
YEARPRICE-TO-EBIT
2026 est -0.01
2025 -6.43
2024 -6.44
2023 -1.85
2022 -5.95
2021 -1,786.20
2020 -139.21
2019 -6.23
2018 -3.94
2017 3.46
2016 -
2015 7.80
2014 6.51
2013 9.94
2012 -0.22
2011 1.31
2010 -0.14
2009 -0.03
2008 -
2007 -0.01
2006 -
Access this data via the Eulerpool API

Global Health Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Global Health's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Global Health's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Global Health's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Global Health grows earnings faster than its peers.

Global Health Stock analysis

What does Global Health do? Global Health Ltd is a British company that has been operating in the healthcare industry since 2004. Its foundation was a response to the increasing demand for better access to healthcare in developing countries. The company has continuously expanded and improved its business model to meet the changing demands of the healthcare industry. An important aspect of Global Health Ltd's business model is its collaboration with governments and non-governmental organizations (NGOs). The company provides comprehensive consultation services to assist governments in planning, developing, and implementing healthcare programs. This includes improving vaccination programs, strengthening healthcare systems, and developing strategies to reduce diseases. Through partnerships with NGOs, Global Health Ltd also enables access to healthcare services in rural and remote areas. The company also provides services in the field of medical research and development, working closely with academic institutions, non-profit organizations, and pharmaceutical companies to promote the development of new drugs and vaccines and support clinical research. Global Health Ltd offers specialized divisions focused on specific areas of the healthcare industry. For example, the company provides medical devices and equipment, including mobile healthcare solutions, to meet the increasing importance of digital technology in healthcare. Additionally, Global Health Ltd is involved in training and education for medical professionals, including training programs for healthcare personnel in developing countries and training for pharmaceutical companies and clinical research institutions. Another important division of the company is its healthcare services, operating healthcare centers in various countries, including clinics that offer specialized services such as ophthalmology, gynecology, and obstetrics. These healthcare centers aim to provide high-quality healthcare at affordable costs and serve as important sources of healthcare and prevention in many regions. Global Health Ltd also offers nutritional supplements specifically tailored to the needs of children and pregnant women. These products are developed and manufactured in collaboration with health authorities and NGOs in developing countries to combat malnutrition and deficiencies. Through its diverse offerings and collaborations with governments, NGOs, and other stakeholders, Global Health Ltd is committed to improving access to healthcare worldwide. The company strives to enable sustainable and affordable healthcare for all, making an important contribution to the global health agenda. Global Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Global Health stock

EV/EBIT (Enterprise Value to EBIT) of Global Health is -5.58 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Global Health changed from -3.53 to -5.58, representing a 58.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Global Health since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Global Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Global Health

All Key Metrics — Global Health